Skip to main content
SpringerLink
Log in

Biotechnology

  • Chapter
The Politics of Emerging Strategic Technologies

Part of the book series: St Antony’s Series ((STANTS))

  • 253 Accesses

Abstract

From stem cell research and genetically modified crops to anthrax and the manipulation of disease-causing agents, the science of biotechnology is truly at the centre of politics, religion, ethics and innovation. Biotechnology has enormous potential to improve life expectancy, food production and the treatment of illness and disease. It also has possible applications for the environment, manufacturing industries and in the creation of alternative energies, making it of huge interest to both the public and private sectors.1

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Notes

  1. D. Steele (2004), ‘Danger Lurks in a Biotech World’, The Aquarian, Spring, http://www.aquarianonline.com/Sci-Tech/Steele_Biotech.html, date accessed 11 August 2010.

  2. Biotechnology Industry Organization (BIO) (2008), Guide to Biotechnology 2008 (Washington, D.C.: BIO), http://bio.org/speeches/pubs/er/BiotechGuide2008.pdf, date accessed 17 August 2010, p. 1.

    Google Scholar 

  3. European Commission (2002), Life Sciences and Biotechnology—A Strategy for Europe (Luxembourg: Office for Official Publications of the European Communities), http://ec.europa.eu/biotechnology/pdf/com2002-27_en.pdf, date accessed 11 August 2010, p. 10.

    Google Scholar 

  4. BIO (2008), Guide to Biotechnology 2008, p. 69.

    Google Scholar 

  5. T. Taylor (2010), ‘Biotechnology Industry’, Presentation at the Strategic Technologies and Our Global Future Course, Geneva Centre for Security Policy, Geneva, Switzerland, 15 April.

    Google Scholar 

  6. BIO (2008), Guide to Biotechnology 2008, p. 2.

    Google Scholar 

  7. BIO (2008), Guide to Biotechnology 2008, p. 2.

    Google Scholar 

  8. Ibid.

    Google Scholar 

  9. National Research Council Committee on Advances in Technology and the Prevention of Their Application to Next Generation Biowarfare Threats (2006), Globalization, Biosecurity, and the Future of the Life Sciences (Washington, D.C.: The National Academies Press), p. 86.

    Google Scholar 

  10. S. Singh (2008), ‘Biotech Growth Slows for the First Time in 5 Years’, LiveMint.com, The Wall Street Journal, 15 July, http://www.livemint.com/2008/07/15215237/Biotech-growth-slows-for-first.html, date accessed 11 August 2010.

  11. Ibid.

    Google Scholar 

  12. A. Pollack and D. Wilson (2010), ‘Safety Rules Can’t Keep Up with Biotech Industry’, The New York Times, 27 May, http://www.nytimes.com/2010/05/28/business/28hazard.html?ref=biotechnology, date accessed 25 July 2010.

  13. BIO (2007), Milestones 2006–2007 (Washington, D.C.: BIO), http://www.bio.org/speeches/pubs/milestone07/Milestones2007.pdf, date accessed 26 August 2010, p. 23.

    Google Scholar 

  14. BIO (2008), Guide to Biotechnology 2008, p. 18.

    Google Scholar 

  15. Ibid.

    Google Scholar 

  16. BIO (2008), Guide to Biotechnology 2008, p. 18.

    Google Scholar 

  17. Ibid., p. 19.

    Google Scholar 

  18. Ibid.

    Google Scholar 

  19. Ibid., p. 20.

    Google Scholar 

  20. Ibid.

    Google Scholar 

  21. Ibid., p. 21.

    Google Scholar 

  22. Ibid.

    Google Scholar 

  23. Committee on Developing Biomarker-Based Tools for Cancer Screening, Diagnosis, and Treatment (2007), Cancer Biomarkers: The Promises and Challenges of Improving Detection and Treatment (Washington, D.C.: National Academies Press), p. 1.

    Google Scholar 

  24. Committee on Developing Biomarker-Based Tools for Cancer Screening, Diagnosis, and Treatment (2007), Cancer Biomarkers: The Promises and Challenges of Improving Detection and Treatment, p. 1.

    Google Scholar 

  25. BIO (2008), Guide to Biotechnology 2008, p. 22.

    Google Scholar 

  26. K. Leutwyler (2001), ‘New Micromachined Cantilever Quickly Detects Disease Markers’, Scientific American, 4 September, http://www.scientificamerican.com/article.cfm?id=new-micromachined-cantile, date accessed 11 August 2010.

  27. Ibid.

    Google Scholar 

  28. International Society for Stem Cell Research (ICCSR) (2008), Stem-cell Facts: The Next Frontier? (Deerfield, IL: ICCSR), http://www.isscr.org/public/ISSCR08_PubEdBroch.pdf, date accessed 11 August 2010, p. 2.

    Google Scholar 

  29. Ibid.

    Google Scholar 

  30. Ibid.

    Google Scholar 

  31. Ibid., p. 3.

    Google Scholar 

  32. European Commission (2005), Synthetic Biology: Applying Engineering to Biology, Report of a NEST High-Level Expert Group (Brussels: European Commission), p. 5.

    Google Scholar 

  33. N. Wade (2010), ‘Researchers Say They Created a ‘Synthetic Cell’, The New York Times, 20 May, http://www.nytimes.com/2010/05/21/science/21cell.html, date accessed 11 August 2010.

  34. S. Benner (2010), ‘Q&A: Life, Synthetic Biology and Risk’, BMC Biology, Vol. 8, 78.

    Article  Google Scholar 

  35. A.H. Cordesman (2005), The Challenge of Biological Terrorism (Washington, D.C.: CSIS Press), p. 91.

    Google Scholar 

  36. Cordesman (2005), The Challenge of Biological Terrorism, pp. 12–17.

    Google Scholar 

  37. Cf. J. Parachini (2002), ‘Control Biological Weapons, but Defend Biotechnology’, RAND Review, Vol. 26, No. 2, 34–35.

    Google Scholar 

  38. Cordesman (2005), The Challenge of Biological Terrorism, p. 93.

    Google Scholar 

  39. Ibid., p. 185.

    Google Scholar 

  40. Committee on Research Standards and Practices to Prevent the Destructive Application of Biotechnology (2004), Biotechnology Research in an Age of Terrorism (Washington, DC: National Academies Press), p. 43.

    Google Scholar 

  41. Ibid., p. 44.

    Google Scholar 

  42. Cordesman (2005), The Challenge of Biological Terrorism, p. 95.

    Google Scholar 

  43. Cordesman (2005), The Challenge of Biological Terrorism, p. 96.

    Google Scholar 

  44. Committee on Research Standards and Practices to Prevent the Destructive Application of Biotechnology (2004), Biotechnology Research in an Age of Terrorism, p. 16.

    Google Scholar 

  45. Ibid.

    Google Scholar 

  46. Cf. J.D. Steinbruner, E.D. Harris, N. Galladher and S.M. Okutani (2005), Controlling Dangerous Pathogens (College Park, MD: Center for International and Security Studies at Maryland) http://www.cissm.umd.edu/papers/files/pathogens_project_monograph.pdf, date accessed 11 August 2010.

    Google Scholar 

  47. Committee on Advances in Technology and the Prevention of Their Application to Next Generation Biowarfare Threats, Development, Security, and Cooperation Policy and Global Affairs Division, Board on Global Health, Institute of Medicine and National Research Council of the National Academies (2006), Globalization, Biosecurity, and the Future of the Life Sciences (Washington, D.C.: The National Academies Press), pp. 246–250.

    Google Scholar 

  48. N.R.F. Al-Rodhan, L. Nazaruk, M. Finaud and J. Mackby (2008), Global Biosecurity: Towards a New Governance Paradigm (Geneva: Éditions Slatkine), p. 225.

    Google Scholar 

  49. A.H. Zakiri, S. Johnston and B. Tobin (2005), ‘The Biodiplomacy Initiative: Informing Equitable and Ethical Decision-Making for Present and Future Generations’, Work in Progress, Vol. 17, No. 2, Summer, http://www.unu.edu/hq/ginfo/wip/wip17-2-summer2005.pdf, date accessed 11 August 2010, 3.

    Google Scholar 

  50. T.F. Budinger and M.D. Budinger (2006), Ethics of Emerging Strategic Technologies: Scientific Facts and Moral Challenges (Hoboken, NJ: John Wiley & Sons), p. 342.

    Google Scholar 

  51. R.S. Schwartz (2006), ‘The Politics and Promise of Stem-Cell Research’, The New England Journal of Medicine, Vol. 355, No. 12, 21 September, http://content.nejm.org/cgi/content/full/355/12/1189, date accessed 20 August 2010.

    Article  Google Scholar 

  52. G. Harris (2010), ‘U.S. Judge Rules against Obama’s Stem Cel Policy’, The New York Times, 23 August, http://www.nytimes.com/2010/08/24/health/policy/24stem.html?ref=stemcells, date accessed 27 August 2010.

  53. S.G. Stolberg and G. Harris (2010), ‘Stem Cell Ruling Will Be Appealed’, The New York Times, 24 August, http://www.nytimes.com/2010/08/25/health/policy/25stem.html?ref=stemcells, date accessed 27 August 2010.

  54. A. Bonnicksen (2007), ‘Therapeutic Cloning: Politics and Policy’ in B. Steinbock (ed.) The Oxford Handbook of Bioethics (Oxford: Oxford University Press), p. 444.

    Google Scholar 

  55. J. Kuzma (2004), ‘Global Challenges and Biotechnology’, Economic Perspectives, October, 4; K. Pawar, S. P. Pawar, V. A. Patel, H. V. Patel (2010), ‘Promotion of Global Health through Oral Immunotherapy Using Edible Vaccines’, Pharmaceutical Reviews, Vol. 8, No. 1, http://www.pharmainfo.net/reviews/promotion-global-health-through-oral-immunotherapy-using-edible-vaccines, date accessed 10 August 2010.

  56. BIO (2008), Guide to Biotechnology 2008, p. 32.

    Google Scholar 

  57. Ibid.

    Google Scholar 

  58. Ibid.

    Google Scholar 

  59. Ibid., p. 35.

    Google Scholar 

  60. Ibid., p. 36.

    Google Scholar 

  61. Ibid., p. 37.

    Google Scholar 

  62. Committee on Advances in Technology and the Prevention of Their Application to Next Generation Biowarfare Threats et al. (2006), Globalization, Biosecurity, and the Future of the Life Sciences, p. 32.

    Google Scholar 

  63. Ibid., p. 49.

    Google Scholar 

  64. Ibid.

    Google Scholar 

  65. Ibid., p. 52.

    Google Scholar 

  66. M.G. Kortepeter and G.W. Parker (1999), ‘Potential Biological Weapons Threats’, Emerging Infectious Diseases, 1 July, http://www.cdc.gov/ncidod/eid/vol5no4/kortepeter.htm, date accessed 11 August 2010.

Download references

Author information

Authors and Affiliations

  1. St Antony’s College, Oxford University, UK

    Nayef R. F. Al-Rodhan (Senior Member, Senior Scholar in Geostrategy, and Director of the Geopolitics of Globalisation and Transnational Security Programme)

  2. Geneva Centre for Security Policy, Geneva, Switzerland

    Nayef R. F. Al-Rodhan (Senior Member, Senior Scholar in Geostrategy, and Director of the Geopolitics of Globalisation and Transnational Security Programme)

Authors
  1. Nayef R. F. Al-Rodhan
    View author publications

    You can also search for this author in PubMed Google Scholar

Copyright information

© 2011 Nayef R.F. Al-Rodhan

About this chapter

Cite this chapter

Al-Rodhan, N.R.F. (2011). Biotechnology. In: The Politics of Emerging Strategic Technologies. St Antony’s Series. Palgrave Macmillan, London. https://doi.org/10.1057/9780230304949_6

Download citation

Publish with us

Policies and ethics

Search

Navigation